Exp Neurobiol.  2019 Dec;28(6):720-726. 10.5607/en.2019.28.6.720.

B Cell Immunophenotyping and Transcriptional Profiles of Memory B Cells in Patients with Myasthenia Gravis

Affiliations
  • 1Department of Neurology, Seoul National University Hospital, Seoul 03080, Korea.
  • 2Seoul National University College of Medicine and Neuroscience Research Institute, Seoul National University Medical Research Council, Seoul 03080, Korea. nrhong@gmail.com
  • 3Department of Neurology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul 07061, Korea.

Abstract

Myasthenia gravis (MG) is an autoimmune neuromuscular junction disorders mediated by various autoantibodies. Although most patients with MG require chronic immunosuppressive treatment to control disease activity, appropriate surveillance biomarkers that monitor disease activity or potential toxicity of immunosuppressants are yet to be developed. Herein, we investigated quantitative distribution of peripheral blood B cell subsets and transcriptional profiles of memory B cells (CD19+ CD27+) in several subgroups of MG patients classified according to the Myasthenia Gravis Foundation of America (MGFA) Clinical Classification. This study suggests potential immunologic B-cell markers that may guide treatment decision in future clinical settings.

Keyword

Myasthenia gravis; B-lymphocytes; Biomarkers; Flow cytometry; Transcriptome

MeSH Terms

Americas
Autoantibodies
B-Lymphocyte Subsets
B-Lymphocytes*
Biomarkers
Classification
Flow Cytometry
Humans
Immunophenotyping*
Immunosuppressive Agents
Memory*
Myasthenia Gravis*
Neuromuscular Junction Diseases
Transcriptome
Autoantibodies
Biomarkers
Immunosuppressive Agents
Full Text Links
  • EN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr